Healthcare intelligence and Internet content provider Caredata.com, Atlanta, GA, has released the results of their 1999 Commercial Health Plan Survey. The survey reveals that consumer satisfaction with prescription drug plans is higher than satisfaction with overall health plans among the commercial managed care plan members surveyed.
Healthcare intelligence and Internet content provider Caredata.com, Atlanta, GA, has released the results of their 1999 Commercial Health Plan Survey. The survey reveals that consumer satisfaction with prescription drug plans is higher than satisfaction with overall health plans among the commercial managed care plan members surveyed.
Fifty-four percent of the more than 24,000 managed care members surveyed said they were highly satisfied with their health plan, compared to 63% who were highly satisfied with their prescription drug plan. Aspects of pharmacy benefits with which plan members were most satisfied include the "ability to get the best medication" and "convenience of getting refills." Less highly rated was "the amount paid for a prescription (co-pay)."
"The survey results reinforce the continued importance of pharmacy benefits to managed care health plans," said Tony Morgan, vice president of Caredata.com's Consumer Research Group. "Fifty percent of survey participants who have a choice of plans cited prescription drug coverage as one of the top three reasons for selecting a health plan. Satisfaction with the prescription drug plan is often a key driver of overall satisfaction with health plans and their ability to retain members."
The survey also found, however, that overall ratings of pharmacy benefits in managed care have fallen four percentage points in two years, from 67% highly satisfied in 1997 to 63% in 1999.
Two findings from the survey help explain this decline, according to Morgan. "First, in just one year, the number of members paying more than $5 for a generic drug went from 31% to 40%," he said. "Looking at branded medications, those paying more for a prescription rose from 13% in 1998 to 31% in 1999. The fact that the cost and availability of medications are major issues in healthcare today is nothing new, but the speed of change and the force of its impact on consumers is striking." PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.